Baicalin-modified polyethylenimine for miR-34a efficient and safe delivery

Area of Science:

• Biotechnology
• Materials Science
• Molecular Biology

Background:

• Gene delivery vectors are crucial for gene therapy, requiring both security and efficiency.
• Polyethylenimine (PEI) is a common gene carrier, but modifications are needed to enhance its performance and safety.

Purpose of the Study:

• To develop a novel, charge-regulated, and degradable polyethylenimine (PEI) derivative for efficient gene delivery.
• To evaluate the efficacy and safety of the new vector, BA-PEI, for delivering miR-34a for cancer therapy.

Main Methods:

• A condensation reaction was used to synthesize BA-PEI, a modified PEI with hydrophobic and functional modifications.
• BA-PEI was complexed with miR-34a, forming nanoparticles of approximately 100 nm.
• Transfection efficiency was assessed in A549 cells using Western blotting, and anti-tumor activity was evaluated in vitro and in vivo.

Main Results:

• BA-PEI effectively compacted miRNAs into stable nanoparticles with good degradability.
• The BA-PEI/miR-34a complex demonstrated significant anti-tumor activity.
• BA-PEI showed superior security and effectiveness compared to commercial transfection reagents.

Conclusions:

• BA-PEI is a promising, safe, and effective gene delivery vector for miR-34a.
• This novel approach offers a new strategy for miR-34a-based gene therapy, particularly for cancer treatment.